so whats next for cnn, page-3

m80 (matey!) a capital raising isn't necessarily bad- necessary dilution. Unless these companies are self-sustaining, and most ASX companies are not, they'll raise capital. At least we don't have the vile La Jolla to contend with, unlike some of our other biotechs.

As to Bioglobal, they just raised capital, so one can hope that the investors get something out of that, and that the SP rises again. SP rises... like they're supposed to... like CNN should. :)